Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib

Bibliographic Details
Main Authors:	Hochberg, Marc C, Martel-Pelletier, Johanne, Monfort, Jordi, Möller, Ingrid, Castillo, Juan Ramón, Arden, Nigel, Berenbaum, Francis, Blanco, Francisco J, Conaghan, Philip G, Doménech, Gema, Henrotin, Yves, Pap, Thomas, Richette, Pascal, Sawitzke, Allen, du Souich, Patrick, Pelletier, Jean-Pierre
Format:	Online
Language:	English
Published:	BMJ Publishing Group 2016
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717399/

Similar Items

Effectiveness and safety of Glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee
by: Zeng, Chao, et al.
Published: (2015)

Chondroitin and glucosamine sulfate in combination decrease the pro-resorptive properties of human osteoarthritis subchondral bone osteoblasts: a basic science study
by: Tat, Steeve Kwan, et al.
Published: (2007)

Chondroitin sulfate efficacy versus celecoxib on knee osteoarthritis structural changes using magnetic resonance imaging: a 2-year multicentre exploratory study
by: Pelletier, Jean-Pierre, et al.
Published: (2016)

Glucosamine, chondroitin, or placebo for osteoarthritis of hip or knee
Published: (2011)

Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site
by: Monfort, Jordi, et al.
Published: (2006)

Correction: Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease 13 - identification of a new biglycan cleavage site
by: Monfort, Jordi, et al.
Published: (2013)

Implication of microRNA-140 in osteoarthritis
by: Martel-Pelletier, Johanne
Published: (2012)

The Novartis-ILAR Rheumatology Prize 2001 Osteoarthritis: from molecule to man
by: Pelletier, Jean-Pierre, et al.
Published: (2002)

Immunomodulatory and anti-inflammatory effects of chondroitin sulphate
by: du Souich, Patrick, et al.
Published: (2009)

Effects of Glucosamine-Chondroitin Sulfate, Glucosamine-Chondroitin Sulfate-Methylsulfonylmethane, or Placebo in Patients with First and Second Grade of Knee Osteoarthritis: A Double Blind Randomized Controlled Study
by: Wonggokusuma, Erick, et al.
Published: (2014)

Most recent developments in strategies to reduce the progression of structural changes in osteoarthritis: today and tomorrow
by: Pelletier, Jean-Pierre, et al.
Published: (2006)

Is there any scientific evidence for the use of glucosamine in the management of human osteoarthritis?
by: Henrotin, Yves, et al.
Published: (2012)

Total Knee Replacement as a Knee Osteoarthritis Outcome: Predictors Derived from a 4-Year Long-Term Observation following a Randomized Clinical Trial Using Chondroitin Sulfate
by: Raynauld, Jean-Pierre, et al.
Published: (2013)

Effects of Glucosamine and Chondroitin Sulfate on Cartilage Metabolism in OA: Outlook on Other Nutrient Partners Especially Omega-3 Fatty Acids
by: Jerosch, Jörg
Published: (2011)

Collagen Synthesis in Tenocytes, Ligament Cells and Chondrocytes Exposed to a Combination of Glucosamine HCl and Chondroitin Sulfate
by: Lippiello, Louis
Published: (2007)

Glucosamine and chondroitin sulfate supplementation to treat symptomatic disc degeneration: Biochemical rationale and case report
by: van Blitterswijk, Wim J, et al.
Published: (2003)

Effectiveness and safety of glucosamine and chondroitin for the treatment of osteoarthritis: a meta-analysis of randomized controlled trials
by: Xiaoyue Zhu, et al.
Published: (2018-07-01)

Glucosamine Hydrochloride but Not Chondroitin Sulfate Prevents Cartilage Degradation and Inflammation Induced by Interleukin-1α in Bovine Cartilage Explants
by: Bascoul-Colombo, Cécile, et al.
Published: (2016)

Randomized Trial of Glucosamine and Chondroitin Supplementation on Inflammation and Oxidative Stress Biomarkers and Plasma Proteomics Profiles in Healthy Humans
by: Navarro, Sandi L., et al.
Published: (2015)

Glucosamine and chondroitin sulfate association increases tibial epiphyseal growth plate proliferation and bone formation in ovariectomized rats
by: Wolff, Roberta Bastos
Published: (2014)

Glucosamine
Published: (2009)

Chondroitin sulphate reduces both cartilage volume loss and bone marrow lesions in knee osteoarthritis patients starting as early as 6 months after initiation of therapy: a randomised, double-blind, placebo-controlled pilot study using MRI
by: Wildi, Lukas Martin, et al.
Published: (2011)

Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial
by: Yves Henrotin, et al.
Published: (2017-05-01)

Activation of proteinase-activated receptor 2 in human osteoarthritic cartilage upregulates catabolic and proinflammatory pathways capable of inducing cartilage degradation: a basic science study
by: Boileau, Christelle, et al.
Published: (2007)

Abnormal insulin-like growth factor 1 signaling in human osteoarthritic subchondral bone osteoblasts
by: Massicotte, Frédéric, et al.
Published: (2006)

The shunt from the cyclooxygenase to lipoxygenase pathway in human osteoarthritic subchondral osteoblasts is linked with a variable expression of the 5-lipoxygenase-activating protein
by: Maxis, Kelitha, et al.
Published: (2006)

Egr-1 mediates the suppressive effect of IL-1 on PPARg expression in human OA chondrocytes
by: Nebbaki, Sarah S, et al.
Published: (2012)

Abnormal osteogenesis in osteoarthritis: gone with the Wnt?
by: Lajeunesse, Daniel, et al.
Published: (2012)

Brachystemma calycinum D. Don Effectively Reduces the Locomotor Disability in Dogs with Naturally Occurring Osteoarthritis: A Randomized Placebo-Controlled Trial
by: Moreau, Maxim, et al.
Published: (2012)

NFAT3 and TGF-β/SMAD3 regulate the expression of miR-140 in osteoarthritis
by: Tardif, Ginette, et al.
Published: (2013)

Impact of oral osteoarthritis therapy usage among other risk factors on knee replacement: a nested case-control study using the Osteoarthritis Initiative cohort
by: Marc Dorais, et al.
Published: (2018-08-01)

Levels of serum biomarkers from a two-year multicentre trial are associated with treatment response on knee osteoarthritis cartilage loss as assessed by magnetic resonance imaging: an exploratory study
by: Johanne Martel-Pelletier, et al.
Published: (2017-07-01)

Diacerein: Benefits, Risks and Place in the Management of Osteoarthritis. An Opinion-Based Report from the ESCEO
by: Pavelka, Karel, et al.
Published: (2016)

Effect of chondroitin sulfate on soluble biomarkers of osteoarthritis: a method to analyze and interpret the results from an open-label trial in unilateral knee osteoarthritis patients
by: Möller, Ingrid, et al.
Published: (2016)

Characterization of synovial angiogenesis in osteoarthritis patients and its modulation by chondroitin sulfate
by: Lambert, Cécile, et al.
Published: (2012)

Effects of glucosamine-chondroitin combination on synovial fluid IL-1β, IL-6, TNF-α and PGE2 levels in internal derangements of temporomandibular joint
by: Damlar, İbrahim, et al.
Published: (2015)

Experimental Pharmacology of Glucosamine Sulfate
by: Chiusaroli, Riccardo, et al.
Published: (2011)

Role of glucosamine in the treatment for osteoarthritis
by: Reginster, Jean-Yves, et al.
Published: (2012)

Extracellular localization of galectin-3 has a deleterious role in joint tissues
by: Janelle-Montcalm, Audrée, et al.
Published: (2007)

Knee meniscal extrusion in a largely non-osteoarthritic cohort: association with greater loss of cartilage volume
by: Ding, Changhai, et al.
Published: (2007)